Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 247 results.
User Information
Export Records
  1. 1.   CR1 variants contribute to FSGS susceptibility across multiple populations
  2. Skitchenko, Rostislav; Modrusan, Zora; Loboda, Alexander; Kopp, Jeffrey B; Winkler,Cheryl; Sergushichev, Alexey; Gupta, Namrata; Stevens, Christine; Daly, Mark J; Shaw, Andrey; Artomov, Mykyta
  3. iScience. 2025, Apr 18; 28(4): 112234.
  1. 2.   Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
  2. Happe, Myra; Lynch, Rebecca M; Fichtenbaum, Carl J; Heath, Sonya L; Koletar, Susan L; Landovitz, Raphael J; Presti, Rachel M; Santana-Bagur, Jorge L; Tressler, Randall L; Holman, LaSonji A; Novik, Laura; Roa, Jhoanna C; Rothwell, Ro Shauna; Strom, Larisa; Wang,Jing; Hu, Zonghui; Conan-Cibotti, Michelle; Bhatnagar, Anjali M; Dwyer, Bridget; Ko, Sung Hee; Belinky, Frida; Namboodiri, Aryan M; Pandey, Janardan P; Carroll, Robin; Basappa, Manjula; Serebryannyy, Leonid; Narpala, Sandeep R; Lin, Bob C; McDermott, Adrian B; Boritz, Eli A; Capparelli, Edmund V; Coates, Emily E; Koup, Richard A; Ledgerwood, Julie E; Mascola, John R; Chen, Grace L; Tebas, Pablo
  3. JCI Insight. 2025, Feb 24; 10(4):
  1. 3.   A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib
  2. Curlee, Millicent S; Toledo-Tamula, Mary Anne; Baker, Melissa; Wikstrom, Daniel; Harrison, Cynthia; Rhodes, Amanda; Fagan, Margaret; Tibery,Cecilia; Wolters, Pamela L; Widemann, Brigitte C; Gross, Andrea M; Martin, Staci
  3. Cancers. 2025, Jan 17; 17(2):
  1. 4.   Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials
  2. Guerra-de-Blas, Paola Del Carmen; Marines-Price, Rubria; Milman, Olga; Deal,Danae; Marchand,Jon; Linton,Jessica; Meger, Sue; Rule, John; Holland, Thomas L; Kitonsa, Jonathan; Delph, Yvette
  3. Journal of Clinical and Translational Science. 2024, Oct 15; 8(1): e157.
  1. 5.   SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir
  2. Singh, Kanal; Rubenstein,Kevin; Callier,Viviane; Shaw-Saliba, Katy; Rupert,Adam; Dewar,Robin; Laverdure,Sylvain; Highbarger,Helene; Lallemand,Perrine; Huang, Meei-Li; Jerome, Keith R; Sampoleo, Reigran; Mills, Margaret G; Greninger, Alexander L; Juneja, Kavita; Porter, Danielle; Benson, Constance A; Dempsey, Walla; El Sahly, Hana M; Focht, Chris; Jilg, Nikolaus; Paules, Catharine I; Rapaka, Rekha R; Uyeki, Timothy M; Lane, H Clifford; Beigel, John; Dodd, Lori E
  3. The Journal of Infectious Diseases. 2024, Sep 23; 230(3): 624-634.
  1. 6.   Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014)
  2. Galindo-Fraga, Arturo; Del Carmen Guerra-de-Blas, Paola; Ortiz-Hernández, Ana A; Rubenstein,Kevin; Ortega-Villa, Ana M; Ramírez-Venegas, Alejandra; Valdez-Vázquez, Rafael; Moreno-Espinosa, Sarbelio; Llamosas-Gallardo, Beatriz; Pérez-Patrigeon, Santiago; Noyola, Daniel E; Magaña-Aquino, Martín; Vilardell-Dávila, Ana; Guerrero, M Lourdes; Powers, John H; Beigel, John; Ruiz-Palacios, Guillermo M
  3. IJID Regions. 2024, Sep; 12: 100394.
  1. 7.   Genomic profiles and clinical presentation of chordoma
  2. Koka, Hela; Zhou,Weiyin; McMaster, Mary L; Bai, Jiwei; Luo,Wen; Klein, Alyssa; Zhang, Tongwu; Hua,Xing; Li, Xin; Wang,Difei; Xiong, Yujia; Jones,Kristine; Vogt,Aurelie; Hicks,Belynda; Parry, Dilys; Goldstein, Alisa M; Yang, Xiaohong R
  3. Acta Neuropathologica Communications. 2024, Aug 12; 12(1): 129.
  1. 8.   Focusing HIV-1 Gag T-cell Responses to Highly Conserved Regions by DNA Vaccination in HVTN 119
  2. Kalams, Spyros A; Felber,Barbara; Mullins, James I; Scott, Hyman M; Allen, Mary A; De Rosa, Stephen C; Heptinstall, Jack; Tomaras, Georgia D; Hu, Jiani; deCamp, Allan C; Rosati,Margherita; Bear,Jenifer; Pensiero, Michael N; Eldridge, John; Egan, Michael A; Hannaman, Drew; McElrath, M Juliana; Pavlakis,George
  3. JCI Insight. 2024, Aug 01;
  1. 9.   Lessons learned: establishing a CLIA-equivalent laboratory for targeted mass spectrometry assays - navigating the transition from research to clinical practice
  2. Han, Chia-Li; Lai, Chi-Ting; Reyes, Aaron James; Yang, Hao-Chin; Lu, Jin-Ying; Shih, Shyang-Rong; Chen, Kuen-Yuan; Hoofnagle, Andrew N; Yu, Sung-Liang; Bocik, William; Hiltke, Tara; Chiu, Huan-Chi; Wan, Ching-Yi; Rodriguez, Henry; Zhang, Victoria; Chen, Yu-Ju
  3. Clinical Proteomics. 2024, Feb 22; 21(1): 12.
  1. 10.   Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials
  2. Merker, Vanessa L; Thompson, Heather L; Wolters, Pamela L; Buono, Frank D; Hingtgen, Cynthia M; Rosser, Tena; Barton, Belinda; Barnett, Carolina; Smith, Taylor; Haberkamp, Diana; McManus, Miranda L; Baldwin,Andrea; Moss, Irene P; Röhl, Claas; Martin, Staci
  3. Clinical Trials (London, England). 2023, Dec 23; 17407745231205577.
  1. 11.   Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
  2. Mittra, Arjun; Coyne, Geraldine H O' Sullivan; Zlott, Jennifer; Kummar, Shivaani; Meehan, Robert; Rubinstein, Lawrence; Juwara,Lamin; Wilsker,Deborah; Ji,Jay; Miller,Brandon; Navas, Tony; Ferry-Galow,Katherine; Voth,Andrea; Chang,Ting-Chia; Jiwani,Shahanawaz; Parchment,Ralph; Doroshow, James H; Chen, Alice P
  3. Cancer Chemotherapy and Pharmacology. 2023, Nov 27;
  1. 12.   Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey
  2. Wolters, Pamela L; Al Ghriwati,Nour; Baker, Melissa; Martin, Staci; Berg, Dale; Erickson, Gregg; Franklin, Barbara; Merker, Vanessa L; Oberlander, Beverly; Reeve, Stephanie; Rohl, Claas; Rosser, Tena; Vranceanu, Ana-Maria
  3. Clinical Trials (London, England). 2023, Nov 14;
  1. 13.   Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS
  2. Rao, V Koneti; Kulm,Elaine; Šedivá, Anna; Plebani, Alessandro; Schuetz, Catharina; Shcherbina, Anna; Dalm, Virgil A; Trizzino, Antonino; Zharankova, Yulia; Webster, Sharon; Orpia, Alanvin; Körholz, Julia; Lougaris, Vassilios; Rodina, Yulia; Radford, Kath; Bradt, Jason; Relan, Anurag; Holland, Steven M; Lenardo, Michael J; Uzel, Gulbu
  3. The Journal of Allergy and clinical immunology.. 2023, Oct 03;
  1. 14.   A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
  2. McDermott, David H; Velez, Daniel; Cho, Elena; Cowen, Edward W; DiGiovanna, John J; Pastrana, Diana V; Buck, Christopher B; Calvo, Katherine R; Gardner, Pamela J; Rosenzweig, Sergio D; Stratton, Pamela; Merideth, Melissa A; Kim, H Jeffrey; Brewer, Carmen; Katz, James D; Kuhns,Doug; Malech, Harry L; Follmann, Dean; Fay, Michael P; Murphy, Philip M
  3. The Journal of Clinical Investigation. 2023, Oct 2; 133(19): e164918.
  1. 15.   Perspectives on Advancing Countermeasures for Filovirus Disease: Report from a Multi-Sector Meeting
  2. Sprecher, Armand; Cross, Robert; Marzi, Andrea; Martins, Karen A; Wolfe, Daniel; Montgomery, Joel M; Spiropoulou, Christina F; Cihlar, Tomas; Ahuka-Mundeke, Steve; Nyhuis, Tara; Teicher, Carrie; Crozier,Ian; Strong, Jim; Kobinger, Gary; Woolsey, Courtney; Geisbert, Thomas W; Feldmann, Heinz; Muyembe, Jean-Jacques
  3. The Journal of Infectious Diseases. 2023, Aug 19;
  1. 16.   Plasmodium falciparum malaria is associated with increased KSHV seropositivity and higher KSHV antibody breadth and magnitude: results of a case-control study from rural Uganda
  2. Nalwoga, Angela; Sabourin, Katherine R; Miley,Wendell; Jackson, Conner; Maktabi, Mahdi; Labo,Nazzarena; Mugisha, Joseph; Whitby,Denise; Rochford, Rosemary; Newton, Robert
  3. The Journal of Infectious Diseases. 2023, Aug 04;
  1. 17.   A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
  2. Atkins, Sarah L P; Greer, Yoshimi Endo; Jenkins, Sarah; Gatti-Mays, Margaret E; Houston, Nicole; Lee, Sunmin; Lee, Min-Jung; Rastogi, Shraddha; Sato, Nahoko; Burks,Christina; Annunziata, Christina M; Lee, Jung-Min; Nagashima, Kunio; Trepel, Jane B; Lipkowitz, Stanley; Zimmer, Alexandra S
  3. The Oncologist. 2023, Jun 05;
  1. 18.   Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case
  2. Ortega-Villa, Ana M; Hynes, Noreen A; Levine, Corri B; Yang, Katherine; Wiley, Zanthia; Jilg, Nikolaus; Wang,Jing; Whitaker, Jennifer A; Colombo, Christopher J; Nayak, Seema U; Kim, Hannah Jang; Iovine, Nicole M; Ince, Dilek; Cohen, Stuart H; Langer, Adam J; Wortham, Jonathan M; Atmar, Robert L; El Sahly, Hana M; Jain, Mamta K; Mehta, Aneesh K; Wolfe, Cameron R; Gomez, Carlos A; Beresnev, Tatiana; Mularski, Richard A; Paules, Catharine I; Kalil, Andre C; Branche, Angela R; Luetkemeyer, Annie; Zingman, Barry S; Voell, Jocelyn; Whitaker, Michael; Harkins, Michelle S; Davey, Richard T; Grossberg, Robert; George, Sarah L; Tapson, Victor; Short, William R; Ghazaryan, Varduhi; Benson, Constance A; Dodd, Lori E; Sweeney, Daniel A; Tomashek, Kay M
  3. Open Forum Infectious Diseases. 2023, Jun; 10(6): ofad290.
  1. 19.   Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
  2. Monge, Cecilia; Xie, Changqing; Myojin, Yuta; Coffman, Kelley; Hrones, Donna Mabry; Wang, Sophie; Hernandez, Jonathan M; Wood, Bradford J; Levy, Elliot B; Juburi, Israa; Hewitt, Stephen M; Kleiner, David E; Steinberg, Seth M; Figg, William D; Redd, Bernadette; Homan,Philip; Cam, Maggie; Ruf, Benjamin; Duffy, Austin G; Greten, Tim F
  3. Journal for Immunotherapy of Cancer. 2023, Feb; 11(2):
  1. 20.   CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells
  2. Brault, Julie; Liu, Taylor; Liu,Siyuan; Lawson, Amanda; Choi, Uimook; Kozhushko, Nikita; Bzhilyanskaya, Vera; Pavel-Dinu, Mara; Meis, Ronald J; Eckhaus, Michael A; Burkett,Sandra; Bosticardo, Marita; Kleinstiver, Benjamin P; Notarangelo, Luigi D; Lazzarotto, Cicera R; Tsai, Shengdar Q; Wu, Xiaolin; Dahl, Gary A; Porteus, Matthew H; Malech, Harry L; De Ravin, Suk See
  3. Frontiers in Immunology. 2023, Jan 4; 13: 1067417.
  1. 21.   Insights into HIV-1 Transmission Dynamics Using Routinely Collected Data in the Mid-Atlantic United States
  2. Kassaye, Seble G; Grossman, Zehava; Vengurlekar, Priyanka; Chai, William; Wallace, Megan; Rhee, Soo-Yon; Meyer, William A; Kaufman, Harvey W; Castel, Amanda; Jordan, Jeanne; Crandall, Keith A; Kang, Alisa; Kumar, Princy; Katzenstein, David A; Shafer, Robert W; Maldarelli,Frank
  3. Viruses. 2022, Dec 25; 15(1):
  1. 22.   Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
  2. Li, Qing Kay; Hu, Yingwei; Chen, Lijun; Schnaubelt, Michael; Cui Zhou, Daniel; Li, Yize; Lu, Rita Jui-Hsien; Thiagarajan,Mathangi; Hostetter, Galen; Newton, Chelsea J; Jewell, Scott D; Omenn, Gil; Robles, Ana I; Mesri, Mehdi; Bathe, Oliver F; Zhang, Bing; Ding, Li; Hruban, Ralph H; Chan, Daniel W; Zhang, Hui
  3. Clinical proteomics. 2022, Oct 20; 19(1): 36.
  1. 23.   Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption
  2. Lau, Chuen-Yen; Adan, Matthew A; Earhart, Jessica; Seamon, Cassie; Nguyen,Thuy; Savramis, Ariana; Adams, Lindsey; Zipparo, Mary-Elizabeth; Madeen,Erin; Huik, Kristi; Grossman, Zehava; Chimukangara, Benjamin; Wulan, Wahyu Nawang; Millo, Corina; Nath, Avindra; Smith, Bryan R; Ortega-Villa, Ana M; Proschan, Michael; Wood, Bradford J; Hammoud, Dima A; Maldarelli,Frank
  3. Frontiers in Medicine. 2022, Aug; 9: 979756.
  1. 24.   Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants
  2. Monteil, Vanessa; Eaton, Brett; Postnikova, Elena; Murphy, Michael; Braunsfeld, Benedict; Crozier,Ian; Kricek, Franz; Niederhöfer, Janine; Schwarzböck, Alice; Breid, Helene; Devignot, Stephanie; Klingström, Jonas; Thålin, Charlotte; Kellner, Max J; Christ, Wanda; Havervall, Sebastian; Mereiter, Stefan; Knapp, Sylvia; Sanchez Jimenez, Anna; Bugajska-Schretter, Agnes; Dohnal, Alexander; Ruf, Christine; Gugenberger, Romana; Hagelkruys, Astrid; Montserrat, Nuria; Kozieradzki, Ivona; Hasan Ali, Omar; Stadlmann, Johannes; Holbrook, Michael R; Schmaljohn, Connie; Oostenbrink, Chris; Shoemaker, Robert H; Mirazimi, Ali; Wirnsberger, Gerald; Penninger, Josef M
  3. EMBO Molecular Medicine. 2022, Jul 04; e15230.
  1. 25.   Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2
  2. Fintzi, Jonathan; Bonnett,Tyler; Tebas, Pablo; Marconi, Vincent C; Levine, Corri B; El Sahly, Hana M; McLellan, Susan L F; Benson, Constance A; Rostad, Christina A; Ganesan, Anuradha; Huprikar, Nikhil; Frank, Maria G; Mularski, Richard A; Atmar, Robert L; Park, Pauline K; Short, William R; Beigel, John H; Mehta, Aneesh K; Sweeney, Daniel A
  3. Open forum infectious diseases. 2022, Jul; 9(7): ofac219.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel